Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
EU — Italia · scadenza 13/04/2027
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Scadenza: 13/04/2027
Fonte: eu_funding_tenders
Tipo: EU
Pagina ufficiale: Apri la scheda sulla fonte ufficiale
Scheda (fonte ufficiale)
Topic metadata
- EU Programme: Horizon Europe (ID 43108390)
- Call identifier: HORIZON-HLTH-2027-01
- Call name: Cluster 1 - Health (Single stage - 2027/1)
- Type: Topic
- Opening date: 10/02/2027
- Next deadline: 13/04/2027
- Keywords: HORIZON-HLTH-2027-01-DISEASE-05, HORIZON-HLTH-2027-01, Clinical development, Phase I, Clinical trials, Cohort studies, Disease control, Drug development, clinical phases, Emerging Epidemics
Topic description
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- The scientific and clinical communities have a better understanding of
Iscriviti o accedi per leggere e ricevere aggiornamenti sui finanziamenti.
Iscriviti oraHai già un account? Accedi